glp-1 side effects cancer Ozempic and Drugs: Risk of Severe GLP-1s may reduce cancer risk
Description
62 HeitmannB
Any deviation from licensed dosing regimens should only occur under close medical supervision, as the risk-benefit profile at sub-therapeutic doses remains poorly characterised and may not provide the intended clinical outcomes
A modest but significant LBM loss (2%) also occurred
Working closely with healthcare providers, individuals can make informed decisions about incorporating Mounjaro into their diabetes management plans and embark on a journey towards improved health and well-being
doi: 10.1007/s00125-005-0128-9 [DOI] [PubMed] [Google Scholar] 49
